These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15073676)

  • 21. Viral sequence evolution in Chinese genotype 1b chronic hepatitis C patients experiencing unsuccessful interferon treatment.
    Xiang X; Lu J; Dong Z; Zhou H; Tao W; Guo Q; Zhou X; Bao S; Xie Q; Zhong J
    Infect Genet Evol; 2011 Mar; 11(2):382-90. PubMed ID: 21147266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of hepatitis C virus before and after interferon treatment in patients with ongoing viraemia but sustained biochemical response.
    Donadel E; Pontisso P; Ruvoletto MG; Gerotto M; De Salvo G; Chemello L; Casarin C; Alberti A
    J Med Virol; 1998 Jan; 54(1):7-11. PubMed ID: 9443103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low rate of sustained virological response in an outbreak of acute hepatitis C in HIV-infected patients.
    Laguno M; Martínez-Rebollar M; Perez I; Costa J; Larrousse M; Calvo M; Loncá M; Muñoz A; González-Cordón A; Blanco JL; Martínez E; Gatell JM; Mallolas J
    AIDS Res Hum Retroviruses; 2012 Oct; 28(10):1294-300. PubMed ID: 22428909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hepatitis C].
    Moradpour D; Blum HE
    Ther Umsch; 2004 Aug; 61(8):493-8. PubMed ID: 15457965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sustained virological response to interferon-α plus ribavirin decreases inflammation and endothelial dysfunction markers in HIV/HCV co-infected patients.
    Guzmán-Fulgencio M; Berenguer J; de Castro IF; Micheloud D; López JC; Cosín J; Miralles P; Lorente R; Aldamiz-Echevarría T; Muñoz-Fernández MÁ; Resino S
    J Antimicrob Chemother; 2011 Mar; 66(3):645-9. PubMed ID: 21393232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ribavirin and interferon for recurrent posttransplantation HCV infection: to treat or not to treat?
    McHutchison JG
    Hepatology; 1997 Aug; 26(2):505-6. PubMed ID: 9252167
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of chronic hepatitis C.
    Reichard O
    Scand J Infect Dis Suppl; 1994; 95():1-56. PubMed ID: 7939437
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hepatitis C virus genotype 4: epidemiology and treatment].
    Castera L; Morice Y; Grando V; Bon C; Dény P; Roulot D
    Gastroenterol Clin Biol; 2003 Jun; 27(6-7):596-604. PubMed ID: 12910223
    [No Abstract]   [Full Text] [Related]  

  • 29. Seroepidemiologic study of HCV genotypes in the district of Messina and Catania.
    Giunta E; Costa L; Saglimbeni L; Arena M; Giachino N
    Eur Rev Med Pharmacol Sci; 1997; 1(1-3):53-5. PubMed ID: 9444799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the third most common genotype of hepatitis C virus in France.
    Li JS; Vitvitski L; Tong SP; Mechai S; Berthillon P; Trépo C
    J Hepatol; 1995; 22(1 Suppl):74-82. PubMed ID: 7602082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevalence of hepatitis C virus infection among chronic hemodialysis patients].
    Tuyuguchi M; Saitou M; Kukita K; Kawamura A
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):319-22. PubMed ID: 15359812
    [No Abstract]   [Full Text] [Related]  

  • 32. The protein kinase-interacting domain in the hepatitis C virus envelope glycoprotein-2 gene is highly conserved in genotype 1-infected patients treated with interferon.
    Polyak SJ; Nousbaum JB; Larson AM; Cotler S; Carithers RL; Gretch DR
    J Infect Dis; 2000 Aug; 182(2):397-404. PubMed ID: 10915068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Distribution of hepatitis C virus genotype in Dalian].
    Xie Y; Xie C
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):872-3. PubMed ID: 19958651
    [No Abstract]   [Full Text] [Related]  

  • 34. Limited success of HCV antiviral therapy in United States veterans.
    Cawthorne CH; Rudat KR; Burton MS; Brown KE; Luxon BA; Janney CG; Fimmel CJ
    Am J Gastroenterol; 2002 Jan; 97(1):149-55. PubMed ID: 11808940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HCV genotype 5: an orphan virus.
    Antaki N; Abboud D; Antaki F; Craxi A
    Antivir Ther; 2013; 18(3):263-9. PubMed ID: 23111702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of transfusion-dependent thalassemic patients infected with hepatitis C virus with interferon alpha-2b and ribavirin.
    Sherker AH; Senosier M; Kermack D
    Hepatology; 2003 Jan; 37(1):223. PubMed ID: 12500209
    [No Abstract]   [Full Text] [Related]  

  • 37. Retreatment of hepatitis C patients who do not respond to interferon: the search continues.
    Pianko S; McHutchison J
    Am J Gastroenterol; 2000 May; 95(5):1122-4. PubMed ID: 10811315
    [No Abstract]   [Full Text] [Related]  

  • 38. High rate of infection with hepatitis C virus genotype 4 in a district of galicia, Spain.
    Martinez SM; Delgado MB; Castroagudín JF; Aguilera A
    J Clin Microbiol; 2005 Oct; 43(10):5403-4. PubMed ID: 16208032
    [No Abstract]   [Full Text] [Related]  

  • 39. The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report.
    Antaki N; Craxi A; Kamal S; Moucari R; Van der Merwe S; Haffar S; Gadano A; Zein N; Lai CL; Pawlotsky JM; Heathcote EJ; Dusheiko G; Marcellin P
    Liver Int; 2010 Mar; 30(3):342-55. PubMed ID: 20015149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hepatitis C virus genotype 5 in Mexico: a case report with successful treatment and a literature review].
    Rubio-Lezama MA; López-Alférez R; Santillán-Arreygue L; Romero-Figueroa M
    Rev Gastroenterol Mex; 2013; 78(3):191-5. PubMed ID: 23972822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.